首页 | 本学科首页   官方微博 | 高级检索  
     


Butein,a novel dual inhibitor of MET and EGFR,overcomes gefitinib‐resistant lung cancer growth
Authors:Sung Keun Jung  Mee‐Hyun Lee  Do Young Lim  Sung Young Lee  Chul‐Ho Jeong  Jong Eun Kim  Tae Gyu Lim  Hanyong Chen  Ann M. Bode  Hyong Joo Lee  Ki Won Lee  Zigang Dong
Affiliation:1. The Hormel Institute, University of Minnesota, Austin, Minnesota;2. Department of Agricultural Biotechnology, Seoul National University, Seoul, Republic of Korea;3. Functional Food Resources Research Group, Korea Food Research Institute, Seongnam, Republic of Korea;4. College of Pharmacy, The Catholic University of Korea, Bucheon, Gyeonggi‐do, Republic of Korea;5. College of Pharmacy, Keimyung University, Daegu, Republic of Korea;6. Advanced Institutes of Convergence Technology, Seoul National University, Suwon, Gyeonggi‐do, South Korea
Abstract:
Keywords:EGFR  MET  butein  acquired‐resistance cancer  lung cancer
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号